Roche Applied Science Industrial Business” Now Is “Roche Custom Biotech
Effectively July 1, Roche Applied Science Industrial Business was relaunched under the name Roche Custom Biotech. The switch will be accompanied by a complete makeover of the Industrial Business appearance. Besides the new name and slogan – “Expertise you can trust” - there will also be a new web appearance, which is integrated in the Roche Applied Science website. The dedicated objective of the initiative is to increase brand recognition in the life science, pharmaceutical, and diagnostic industry.
“The main goal of the new brand Roche Custom Biotech is to sharpen our profile in the Biotech B2B industry. The brand expresses our outstanding competence and experience in serving our customers in manufacturing.”, said Manfred Baier, Head of Roche Applied Science.
Roche Custom Biotech has been manufacturing and supplying industrial chemistries for thirty years, in particular for use in the diagnostics industry. With a portfolio of over one thousand products, Roche Custom Biotech also custom manufactures to customer needs.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Last viewed contents
The Safe Transfer and Assay of Infectious Agents - Labcyte Awarded U. S. Patent for Transferring Liquids within Sealed Containers
American_Association_of_Colleges_of_Pharmacy
AbbVie Announces New Phase 3b Results in Genotype 1b Chronic Hepatitis C Patients with Compensated Liver Cirrhosis
Sigma® Life Science and King's College London co-developing miRNA Target Identification Technology
Stress affects brain’s blood flow
European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz
